10.58 am | 24 May 2013 |  Source: Moneycontrol.com

Glenmark Pharma's generics arm has recalled multiple lots of three drugs from the US market due to an odd smell, according to the US drug regulator. T...

7.00 pm | 20 May 2013 |  Source: Moneycontrol.com

At first glance, it appeared the new Drug Pricing Control Order was to blame. But there were other factors as well. Here are the reasons…...

11.48 am | 17 May 2013 |  Source: Reuters

The policy, which will curtail prices of costly brands sold by domestic and international drugmakers, was approved by the government in November....

10.36 am | 17 May 2013 |  Source: Moneycontrol.com

The Department of Pharmaceuticals on Thursday notified Drug Price Control Order 2013. Once implemented over next few months, prices of 348 essential d...

12.21 pm | 15 May 2013 |  Source: Moneycontrol.com

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approvals (ANDA’s) from the USFDA for Zolmit...

10.01 am | 15 May 2013 |  Source: CNBC-TV18

One can buy Glenmark Pharma, says Sudarshan Sukhani of s2analytics.com. Its charts are excellent and it is making new highs, he adds....

7.13 pm | 14 May 2013 |  Source: Moneycontrol.com

After last week's rally experts believe that Nifty will be drifting downward for few more sessions and hence short bias is advised. Q4 GDP data would ...

11.01 pm | 13 May 2013 |  Source: CNBC-TV18

CNBC-TV18’s Archana Shukla reports that Glenmark Pharma, faced with a slowdown in the Indian market, is now focusing on the strategy for growth in t...

2.58 pm | 13 May 2013 |  Source: Moneycontrol.com

Brokerage house FinQuest Securities has maintained its 'Hold' rating on Glenmark Pharmaceuticals with a price target Rs 536, in its May 13, 2013 resea...

1.36 pm | 13 May 2013 |  Source: CNBC-TV18

According to Sudarshan Sukhani of s2analytics.com Glenmark Pharma can touch Rs 700 in the next two years or more....

1.57 pm | 10 May 2013 |  Source: CNBC-TV18

After Indian market rallying high in the past couple of trading sessions, Sandeep Singal of Emkay Global feels the midcaps will keep the Nifty in the ...

8.49 pm | 09 May 2013 |  Source: CNBC-TV18

CNBC-TV18’s Archana Shukla reports that the pharma sector’s fortunes in the January-March quarter were dictated by the US market while the sector'...

6.54 pm | 09 May 2013 |  Source: Moneycontrol.com

Glenmark Pharmaceuticals at the meeting of the board of directors held on May 07, 2013, Mr. Marshall Mendonza - Vice President & Company Secretary cea...

1.12 pm | 09 May 2013 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Manoj Garg, VP, Institutional Equities - Research, Edelweiss Securities shares his outlook on the pharmaceutical compani...

6.38 pm | 08 May 2013 |  Source: CNBC-TV18

Rajen Shah of Angel Broking said he would buy Glenmark. According to him, the stock may rise 15 percent....

4.18 pm | 08 May 2013 |  Source: CNBC-TV18

In CNBC-TV18's popular show Bull's Eye, Prakash Diwan of Prakash Diwan's Wealth Circle shares his trading strategies for the day....

12.21 pm | 08 May 2013 |  Source: CNBC-TV18

Ranbaxy's first quarter net profit is seen at Rs 173 crore, compared with a Rs 1,246 crore profit in the year ago quarter, according to a CNBC-TV18 po...

11.14 am | 08 May 2013 |  Source: CNBC-TV18

Pharma major Glenmark says the operating environment is challenging given the slowdown in India and longer time taken by the US drug regulator for pro...

11.10 am | 08 May 2013 |  Source: CNBC-TV18

Rajen Shah of Angel Broking feels the rally may now spill over into the smallcap and midcap space. "We have been having a fabulous rally in the frontl...

9.50 am | 08 May 2013 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...